Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
British Journal of Pharmacology|December 17, 2013
Vascular targets for cannabinoids: animal and human studiesChristopher Stanley, Saoirse E O'SullivanAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
The Role of Nuclear Hormone Receptors in Cannabinoid FunctionMarco Pistis, Saoirse E O'SullivanPharmacological Research|February 20, 2014
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteriesChristopher P Stanley, Saoirse E O'SullivanCannabis and Cannabinoid Research|January 25, 2023
Origins of <i>Cannabis sativa</i> in Ireland and the Concept of Celtic Hemp: An Interdisciplinary ReviewJohn M McPartland, Saoirse E O'SullivanProstaglandins & Other Lipid Mediators|November 13, 2022
Endocannabinoid hydrolases differentially distribute in platelets and red blood cells and are differentially released by thrombinNuha Anajirih, Saoirse E O'Sullivan, Stephen Ph AlexanderJournal of Cellular Physiology|April 27, 2019
Human vascular cell responses to the circulating bone hormone osteocalcinSophie A Millar, Susan I Anderson, Saoirse E O'sullivanBritish Journal of Pharmacology|February 11, 2004
Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)Saoirse E O'Sullivan, David A Kendall, Michael D RandallPPAR Research|May 8, 2009
Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ)Saoirse E O'Sullivan, David A Kendall, Michael D RandallJCI Insight|June 15, 2017
A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover studyKhalid A Jadoon, Garry D Tan, Saoirse E O'SullivanBritish Journal of Clinical Pharmacology|June 8, 2012
Is the cardiovascular system a therapeutic target for cannabidiol?Christopher P Stanley, William H Hind, Saoirse E O'SullivanPageof 7